MarginsXMarginsX
Home › Markets › MEOBF

Mesoblast LTD (MEOBF)

MEOBF is quoted over the counter, not listed on an exchange. Mesoblast LTD files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Last trade · November 4, 2026
$1.14
No trades since Nov 4, 2026; later closes repeat the last quote
1-year return
-15.6%
Market cap
The company also trades on Nasdaq as MESO; this OTC line is another class or a foreign line, so its cap is not computed
P/E and P/S
Needs a market cap · Needs a market cap
On fiscal year to June 30, 2026 (20-F)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerMEOBF, quoted over the counter
SEC CIK0001345099
OTC Markets tierPink (price source, 2026-11-13)
SEC industry codeBiological Products, (No Diagnostic Substances)
Business addressMelbourne, Victoria, Australia
Incorporated inAustralia

Warning signs

Cash runway
28.2 months
$102.9M cash at June 30, 2026
Share count, 1 year
+1.3%
2025-06-30 to 2026-06-30 · +218.6% over 3 years
Going-concern doubt
No
20-F filed August 27, 2026
Insider net buying, 12 months
$19.6M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.20-F 2026-08-27
Cash and burn$102.9M cash; operating cash flow -$11.0M a quarter.Report 2026-06-30
Shares outstanding129,686,278 (2026-06-30); 127,996,719 a year earlier; 81,420,483 three years earlier. 3y figure adjusted for split (1-for-2 overall).Cover page 2026-06-30
Reverse splits, 3 years1; latest 1-for-2 on 2024-01-10Source 2024-01-10
Shelf and offerings, 12 months2 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2025-12-31
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers, Melbourne, AustraliaPCAOB Form AP 2026-09-14
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $19.6M, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2026
2026-06-30
$120.3M-$57.5M-$43.8M$102.9M$119.2M$120.3M20-F 2026-08-27
FY 2025
2025-06-30
$17.2M-$102.1M-$50.0M$161.6M$121.9M$17.2M20-F 2025-08-29
FY 2024
2024-06-30
$5.9M-$88.0M-$48.5M$63.0M$114.3M$5.9M20-F 2025-08-29
FY 2023
2023-06-30
$7.5M-$81.9M-$63.3M$71.3M$108.8M$7.5M20-F 2025-08-29
FY 2022
2022-06-30
$10.2M-$91.3M-$65.8M$60.4M$101.7M$10.2M20-F 2024-08-29
FY 2021
2021-06-30
$7.4M-$98.8M-$100.7M$136.9M$147.4M$7.4M20-F 2023-08-31
FY 2020
2020-06-30
$32.2M-$77.9M-$50.4M$129.3M$89.5M$32.2M20-F 2022-08-31
FY 2019
2019-06-30
$16.7M-$89.8M-$57.8M$50.4M$81.3M$16.7M20-F 2021-08-31

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B32026-01-14
Latest annual report20-F2026-08-27
Latest quarterly / interim6-K2026-11-16

Source: SEC EDGAR submissions feed, 600 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier